Connect & Solve
Trade Q&A
Can Medical Device Products be Exported to the US Without FDA for Customs Clearance?
Resolved
SERVICE
TRACKING NO. 20251229 / GLOBAL Zhongshen Trade · 23+ Years of Expert Trade Agency
Trade Challenges?
No import/export license, customs delays,
or complex compliance issues.
or complex compliance issues.
Our Solution
One-stop full-chain agency: ensure efficient
clearance and fund security.
clearance and fund security.
Cost OptimizationUrgent ClearanceGlobal ResourcesCompliant Rebates
We have a batch of Category II productsI want to...But the FDA 510(k) application is still pending. The client is in a hurry and wants to know if we can ship the goods for customs clearance without FDA certification first. Will the goods be detained by customs? Are there any ways to speed up the process?
Lucas LiuYears of service：8Customer Rating：5.0
Senior Operations ConsultantStart a Chat
Your current situation constitutes an operation that violates regulatory red lines. According to the U.S. Federal Food，Drug，and Cosmetic Act，all medical devices entering the United States must complete FDA registration or listing and obtain corresponding market access. Without FDA certification，the product lacks legal status. After receiving FDA's import alert directives，the U.S. Customs and Border Protection (CBP) has the right to directly detain or even return the goods. More serious consequences include the possibility of the company being listed on the FDA Import Alert List，resulting in automatic detention of all future products. Currently，only two exceptional circumstances may be exempted: one is samples used for clinical trials，which require prior application for an IDE (Investigational Device Exemption) and obtaining FDA import permission，the other is for personal use or exhibition purposes，subject to quantity restrictions and requiring advance declaration. We recommend you immediately stop the shipping plan and prioritize completing the 510(k) approval. If the client urgently needs the products，we can assist them in confirming whether an Emergency Use Authorization (EUA) can be applied，but this only applies to public health emergencies. Compliance is the bottom line - never sacrifice long-term interests for short-term gains.
Kevin LinYears of service：4Customer Rating：5.0
Trade Solutions ManagerStart a Chat
From the perspective of logistics and customs clearance practices, it is nearly impossible to complete US imports without FDA certification. The CBP system is directly connected to the FDA database. After the goods arrive at the port, the customs broker must fill in the FDA product code and manufacturer's registration number in the Entry document. If the system cannot find valid information, the goods will immediately be labeled as "FDA Hold" and transferred to a bonded warehouse for compliance review. This process generates daily storage fees, and over 90% of the goods ultimately end up being returned or destroyed. Not only will you lose freight and customs duties, but you may also face additional fines from the US Environmental Protection Agency for medical waste disposal.
My recommendations are as follows:
1. Immediately stop shipping to avoid incurring high demurrage fees after arrival.
2. If the client insists on receiving the goods, consider temporarily storing them in bonded zones in third countries such as Canada or Mexico. However, this requires cooperation from local distributors and is costly.
3. Simultaneously prepare logistics plans for return shipments and select freight forwarders with experience in handling medical products to ensure rapid return in case of seizure.
The safest approach is to wait for FDA approval before shipping, which will actually make the logistics cycle more predictable.
Michael ZhangYears of service：6Customer Rating：5.0
Customs Declaration & Compliance ExpertStart a Chat
What you need most now is to stabilize your clients and reset reasonable expectations. Directly telling clients "no FDA approval, no customs clearance" may be factually correct, but it might make them question your professionalism. Here’s a suggested communication approach:
1. Clearly explain the mandatory requirements of U.S. law for medical devices, emphasizing that this system protects end-users and demonstrating your compliance awareness.
2. Provide a timeline and current progress of the FDA 510(k) application, showing clients the predictability of the process.
3. Propose a transitional solution: If clients urgently need samples for market promotion or clinical testing, assist them in applying for small-scale sample import permits (FDA allows up to 10 samples per year for non-commercial use), but this requires clients to provide a usage statement.
4. Insist on a payment structure: "Only accept a 30% down payment before FDA approval, and pay the balance after approval and delivery," to avoid unilaterally assuming inventory and compliance risks.
Remember, professional suppliers never promise what they cannot deliver, but they do provide feasible roadmaps. This approach will both maintain client relationships and safeguard your bottom line.